AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Mepixanox (CAS 17854-59-0) Market Research Report, 2019 - ResearchAndMarkets.com

May 23, 2019

DUBLIN--(BUSINESS WIRE)--May 23, 2019--

The “Mepixanox (CAS 17854-59-0) Market Research Report, 2019” report has been added to ResearchAndMarkets.com’s offering.

This report helps to build up a clear view of the market (trends and prospects), identify major players in the industry, and estimate main downstream sectors.

The Key Points

  • Mepixanox description, its application areas and related patterns
  • Mepixanox market situation
  • Mepixanox manufacturers and distributors
  • Mepixanox prices (by region and provided by market players)
  • Mepixanox end-uses breakdown
  • Mepixanox downstream industries trends

Topics Covered

1. MEPIXANOX GENERAL INFORMATION

1.1. General information, synonyms

1.2. Composition, chemical structure

1.3. Safety information

1.4. Hazards identification

1.5. Handling and storage

1.6. Toxicological & ecological information

1.7. Transport information

2. MEPIXANOX APPLICATION

3. MEPIXANOX MANUFACTURING METHODS

4. MEPIXANOX PATENTS

5. MEPIXANOX MARKET WORLDWIDE

5.1. General Mepixanox market situation, trends

5.2. Manufacturers of Mepixanox

  • Europe
  • Asia
  • North America
  • Etc.

5.3. Suppliers of Mepixanox

  • Europe
  • Asia
  • North America
  • Etc.

5.4. Product market forecast

6. MEPIXANOX MARKET PRICES

  • Europe
  • Asia
  • North America

7. MEPIXANOX END-USE SECTOR

For more information about this report visit https://www.researchandmarkets.com/r/fl6ggd

View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005694/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Respiratory Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/23/2019 01:53 PM/DISC: 05/23/2019 01:53 PM

http://www.businesswire.com/news/home/20190523005694/en

All contents © copyright 2019 The Associated Press.All rights reserved.